28 April 2016 - Up to 30,000 Australians living with a slow-growing form of lymphoma could benefit from a new anti-cancer drug.

A form of Ribomustin was first developed in East Germany in the 1960s when access to western treatments was limited.

It has just been approved for Australia’s Pharmaceutical Benefits Scheme.

The drug significantly prolongs the quality and expectancy of life for patients diagnosed with some forms of lymphoma.

For more details, go to: http://www.sbs.com.au/news/article/2016/04/28/anti-cancer-drug-ribomustin-added-pbs